Alterd angiotensin-converting enzyme and its effects on the brain in a rat model of Alzheimer disease

Chinese Medical Journal

Volumn 121, Issue 22, 2008, Pages 2320-2323

  Hou, De Ren ^a   Wang, Yan ^a   Zhou, Lin ^a   Chen, Kun ^a   Tian, Yi ^a   Song, Zhi ^a   Bao, Juan ^a   Yang, Qi Dong ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Alzheimer disease; Amyloid beta protein; Angiotensin converting enzyme; Perindopril

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN[1-42]; CONGO RED; DIPEPTIDYL CARBOXYPEPTIDASE; EOSIN; HEMATOXYLIN; PERINDOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CELL COUNT; CELL STRUCTURE; CONTROLLED STUDY; DOWN REGULATION; ELECTROSTIMULATION; ENZYME ACTIVITY; FEMALE; HIPPOCAMPUS; MAZE TEST; NONHUMAN; PATHOGENESIS; PROTEIN FUNCTION; RAT; SPECTROPHOTOMETRY; ANIMAL; BRAIN; DISEASE MODEL; DRUG EFFECT; ENZYMOLOGY; METABOLISM; NERVE CELL; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZATION; SPRAGUE DAWLEY RAT;

ALZHEIMER DISEASE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; MAZE LEARNING; NEURONS; PEPTIDYL-DIPEPTIDASE A; PERINDOPRIL; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 62749169960     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200811020-00019     Document Type: Article

References (19)

1. Lavoie JL, Sigmund CD. Minireview: overview of the renin-angiotensin system-an endocrine and paracrine system. Endocrinology 2003; 144: 2179-2183.
2. Wright JW, Harding JW. The brain angiotensin system and extracellular matrix molecules in neural plasticity, learning, and memory. Prog Neurobiol 2004; 72: 263-269.
3. Zhao C, Cheng G, Chen Q. A new type of intellectualized Y maze. Chin J Appl Physiol (Chin) 1997; 13: 363-364.
4. Paxinos G, Watson C. The rat brain in stereotactic coordinates. Academic Press; 2004.
5. Wiseman RM, Saxby BK, Burton EJ, Barber R, Ford GA, O'Brien JT. Hippocampal atrophy, whole brain volume, and white matter lesions in older hypertensive subjects. Neurology 2004; 63: 1892-1897.
6. Gurol ME, Irizarry MC, Smith EE, Raju S, Diaz-Arrastia R, Bottiqlieri T, et al. Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy. Neurology 2006; 66: 23-29.
7. Shankar GM, Bloodgood BL, Townsend M, Walsh DM, Selkoe DJ, Sabatini BL. Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci 2007; 27: 2866-2875.
8. Butterfield DA, Reed T, Newman SF, Sultana R. Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment. Free Radic Biol Med 2007; 43: 658-677.
9. Forero DA, Benitez B, Arboleda G, Yunis JJ, Pardo R, Arboleda H. Analysis of functional polymorphisms in three synaptic plasticity-related genes (BDNF, COMT AND UCHL1) in Alzheimer's disease in Colombia. Neurosci Res 2006; 55: 334-341.
10. Ko SH, Hong OK, Kim JW, Ahn YB, Song KH, Cha BY, et al. High glucose increased extracellular matrix production in pancreatic stellate cells by activating the renin-angiotensin system. J Cell Biochem 2006; 98: 343-355.
11. Larkin JE, Frank BC, Gaspard RM, Duka I, Gavras H, Quackenbush J. Cardiac transcriptional response to acute and chronic angiotensin II treatment. Physiol Genomics 2004; 18: 152-166.
12. Lasaitiene D, Chen Y, Mildaziene V, Nauciene Z, Sundelin B, Johansson BR, et al. Tubular mitochondria alterations in neonatal rats subjected to RAS inhibition. Am J Physiol Renal Physiol 2006; 290: F1260-F1269.
13. Boyd-Kimball D, Poon HF, Lynn BC, Cai J, Pierce WM Jr, Klein JB, et al. Proteomic identification of proteins specifically oxidized in Caenorhabditis elegans expressing human A beta (1-42): implications for Alzheimer's disease. Neurobiol Aging 2006; 27: 1239-1249.
14. Marco S, Skaper SD. Amyloid beta-peptide 1-42 alters tight junction protein distribution and expression in brain microvessel endothelial cells. Neurosci Lett 2006; 401: 219-224.
15. Yun SH, Gamkrelidze G, Stine WB, Sullivan PM, Pasternak JF, Ladu MJ, et al. Amyloid-beta 1-42 reduces neuronal excitability in mouse dentate gyrus. Neurosci Lett 2006; 403: 162-165.
16. Benarroch EE. Neurovascular unit dysfunction: a vascular component of Alzheimer disease? Neurology 2007; 68: 1730-1732.
17. Lo EH, Dalkara T, Moskowitz MA. Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 2003; 4: 399-415.
18. Harata T, Ando H, Iwase A, Nagasaka T, Mizutani S, Kikkawa F. Localization of angiotensin II, the AT1 receptor, angiotensin-converting enzyme, aminopeptidase A, adipocyte-derived leucine aminopeptidase, and vascular endothelial growth factor in the human ovary throughout the menstrual cycle. Fertil Steril 2006; 86: 433-439.
19. McKinley MJ, Albiston AL, Allen AM, Mathai ML, May CN, McAllen RM, et al. The brain renin-angiotensin system: location and physiological roles. Int J Biochem Cell Biol 2003; 35: 901-918.